To further establish utility of the pre-targeting approach, ovarian carcinoma cell line OvCAR-3 (EpCAMpos/CD44pos) was pretargeted with anti-EpCAM-FITC or anti-CD44-FITC. Here, CD44 is linked to ovarian carcinoma.